Vanhoutte F, Vereecke J, Carmeliet E, Verbeke N
Laboratory of Clinical Pharmacy, University of Leuven, Belgium.
Naunyn Schmiedebergs Arch Pharmacol. 1991 Dec;344(6):662-73. doi: 10.1007/BF00174750.
Disopyramide, a Class Ia antiarrhythmic drug, is clinically used as a racemic mixture; R(-)disopyramide and S(+)disopyramide. The major metabolite in man is desisopropyldisopyramide: R(-)desisopropyldisopyramide and S(+)desisopropyldisopyramide. The effects of the four compounds were compared on the electrophysiological characteristics of the guinea-pig papillary muscle using the standard microelectrode technique. At an external K+ concentration of 5.4 mmol/l and a stimulation frequency of 1 Hz, S(+)disopyramide (20 mumols/l) increased action potential duration (APD) by more than 18%, while it was diminished by 6% in the presence of R(-)disopyramide. Resting membrane potential amounted to -87.1 +/- 0.5 mV (n = 14) and -85.6 +/- 1.2 mV (n = 10), respectively. Also a small but significant difference in effect on the maximal rate of depolarization was observed, R(-)disopyramide being more potent, related with a slower recovery of the maximal rate of depolarization. The enantiomers of the metabolite appeared to be three times less potent than those of the parent drug in their effect on the maximal rate of depolarization. The characteristics of the enantiomers of the metabolite correlated with those of the parent drug: also the R(-)enantiomer was more potent in decreasing the maximal rate of depolarization and caused more shortening of the action potential than the S(+)enantiomer. Time constants for onset and recovery of/from rate dependent block of the maximal rate of depolarization were dependent upon the external K+ concentration, both for the enantiomers of the parent drug and those of the metabolite. Onset slowed down while recovery accelerated when external K+ was increased. Time constants were lower for the metabolite. When stimulation interval was shortened, the effect on the maximal rate of depolarisation increased. Only for the metabolite statistical significant stereoselective differences were observed at all stimulation intervals. The effects on the action potential duration were dependent upon stimulation interval; for all enantiomers the action potential duration tended to be relatively (% of control) higher at short stimulation intervals than at large stimulation intervals. The effect on the maximal rate of depolarization was also voltage dependent, but no significant differences were observed between the enantiomers, for the parent drug as well as for the metabolite.
丙吡胺是一种Ia类抗心律失常药物,临床上使用的是外消旋混合物,即R(-)丙吡胺和S(+)丙吡胺。人体内的主要代谢产物是去异丙基丙吡胺,即R(-)去异丙基丙吡胺和S(+)去异丙基丙吡胺。采用标准微电极技术,比较了这四种化合物对豚鼠乳头肌电生理特性的影响。在细胞外钾离子浓度为5.4 mmol/L、刺激频率为1 Hz时,S(+)丙吡胺(20 μmol/L)使动作电位时程(APD)增加超过18%,而在R(-)丙吡胺存在时,APD缩短了6%。静息膜电位分别为-87.1±0.5 mV(n = 14)和-85.6±1.2 mV(n = 10)。在对最大去极化速率的影响方面也观察到了微小但显著的差异,R(-)丙吡胺的作用更强,这与最大去极化速率的恢复较慢有关。代谢产物的对映体在对最大去极化速率的影响方面,其效力似乎比母体药物的对映体低三倍。代谢产物对映体的特性与母体药物的特性相关:同样,R(-)对映体在降低最大去极化速率方面更有效,并且比S(+)对映体引起的动作电位缩短更多。最大去极化速率的速率依赖性阻滞的起始和恢复时间常数取决于细胞外钾离子浓度,母体药物的对映体和代谢产物的对映体均如此。当细胞外钾离子浓度增加时,起始减慢而恢复加速。代谢产物的时间常数较低。当刺激间隔缩短时,对最大去极化速率的影响增加。仅在代谢产物中,在所有刺激间隔下均观察到了具有统计学意义的立体选择性差异。对动作电位时程的影响取决于刺激间隔;对于所有对映体,在短刺激间隔下动作电位时程相对(相对于对照的百分比)高于长刺激间隔。对最大去极化速率的影响也与电压有关,但在母体药物和代谢产物的对映体之间未观察到显著差异。